Results 101 to 108 of about 11,064 (108)

Population Pharmacokinetics and Exposure‐Response Relationship of Intravenous and Subcutaneous Abatacept in Patients With Rheumatoid Arthritis

Journal of Clinical Pharmacology, 2019
Xiaohui Li, Amit Roy, Bindu Murthy
exaly  

Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Modern Rheumatology, 2013
Tsutomu Takeuchi, Tsukasa Matsubara, Tohru Abe   +2 more
exaly  

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)

Clinical Rheumatology, 2016
Florenzo Iannone, Maria Victoria Hernández, Elisabeth Lie   +2 more
exaly  

Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis

Clinical Rheumatology, 2010
Michael Schiff, Louis Bessette, Bessette Louis   +2 more
exaly  

Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis

Journal of Autoimmunity, 2005
S Nadler
exaly  

Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis

Drugs, 2013
exaly  

Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients

Modern Rheumatology, 2013
Nobunori Takahashi, Kenya Terabe, Atsushi Kaneko   +2 more
exaly  

Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis

Expert Opinion on Biological Therapy, 2005
Larry W Moreland
exaly